-
1
-
-
0032877586
-
NMDA and non-NMDA receptor-mediated excitotoxicity are potentiated in cultured striatal neurons by prior chronic depolarization
-
10486197 10.1006/exnr.1999.7135 1:CAS:528:DyaK1MXlvVWqs78%3D
-
Chen Q, Surmeier DJ, Reiner A (1999) NMDA and non-NMDA receptor-mediated excitotoxicity are potentiated in cultured striatal neurons by prior chronic depolarization. Exp Neurol 159:283-296
-
(1999)
Exp Neurol
, vol.159
, pp. 283-296
-
-
Chen, Q.1
Surmeier, D.J.2
Reiner, A.3
-
2
-
-
29244479196
-
Proteomic analysis of protein expression and oxidative modification in r6/2 transgenic mice: A model of Huntington disease
-
15968004 10.1074/mcp.M500090-MCP200 1:CAS:528:DC%2BD2MXhtlWqsb7N
-
Perluigi M, Poon HF, Maragos W, Pierce WM, Klein JB, Calabrese V, Cini C, De Marco C, Butterfield DA (2005) Proteomic analysis of protein expression and oxidative modification in r6/2 transgenic mice: a model of Huntington disease. Mol Cell Proteomics 4:1849-1861
-
(2005)
Mol Cell Proteomics
, vol.4
, pp. 1849-1861
-
-
Perluigi, M.1
Poon, H.F.2
Maragos, W.3
Pierce, W.M.4
Klein, J.B.5
Calabrese, V.6
Cini, C.7
De Marco, C.8
Butterfield, D.A.9
-
3
-
-
37749000434
-
Oxidative stress parameters in plasma of Huntington's disease patients, asymptomatic Huntington's disease gene carriers and healthy subjects: A cross-sectional study
-
17990062 10.1007/s00415-007-0611-y 1:CAS:528:DC%2BD1cXhvVCmtb8%3D
-
Klepac N, Relja M, Klepac R, Hećimović S, Babić T, Trkulja V (2007) Oxidative stress parameters in plasma of Huntington's disease patients, asymptomatic Huntington's disease gene carriers and healthy subjects: a cross-sectional study. J Neurol 254:1676-1683
-
(2007)
J Neurol
, vol.254
, pp. 1676-1683
-
-
Klepac, N.1
Relja, M.2
Klepac, R.3
Hećimović, S.4
Babić, T.5
Trkulja, V.6
-
4
-
-
12644252940
-
Striatal glucose metabolism and dopamine D2 receptor binding in asymptomatic gene carriers and patients with Huntington's disease
-
9010012 10.1093/brain/119.6.2085
-
Antonini A, Leenders KL, Spiegel R, Meier D, Vontobel P, Weigell-Weber M, Sanchez-Pernaute R, de Yébenez JG, Boesiger P, Weindl A, Maguire RP (1996) Striatal glucose metabolism and dopamine D2 receptor binding in asymptomatic gene carriers and patients with Huntington's disease. Brain 119(Pt 6):2085-2095
-
(1996)
Brain
, vol.119
, pp. 2085-2095
-
-
Antonini, A.1
Leenders, K.L.2
Spiegel, R.3
Meier, D.4
Vontobel, P.5
Weigell-Weber, M.6
Sanchez-Pernaute, R.7
De Yébenez, J.G.8
Boesiger, P.9
Weindl, A.10
Maguire, R.P.11
-
5
-
-
0026794813
-
Cellular localization of a metabotropic glutamate receptor in rat brain
-
1323311 10.1016/0896-6273(92)90165-A 1:CAS:528:DyaK38XlvVGgs7k%3D
-
Martin LJ, Blackstone CD, Huganir RL, Price DL (1992) Cellular localization of a metabotropic glutamate receptor in rat brain. Neuron 9:259-270
-
(1992)
Neuron
, vol.9
, pp. 259-270
-
-
Martin, L.J.1
Blackstone, C.D.2
Huganir, R.L.3
Price, D.L.4
-
6
-
-
0035960544
-
Coenzyme Q10 and remacemide hydrochloride ameliorate motor deficits in a Huntington's disease transgenic mouse model
-
11716985 10.1016/S0304-3940(01)02326-6 1:CAS:528:DC%2BD3MXosFKqs7k%3D
-
Schilling G, Coonfield ML, Ross CA, Borchelt DR (2001) Coenzyme Q10 and remacemide hydrochloride ameliorate motor deficits in a Huntington's disease transgenic mouse model. Neurosci Lett 315:149-153
-
(2001)
Neurosci Lett
, vol.315
, pp. 149-153
-
-
Schilling, G.1
Coonfield, M.L.2
Ross, C.A.3
Borchelt, D.R.4
-
7
-
-
10644229056
-
Kinetics, pharmacokinetics, and regulation of l-carnitine and acetyl-l-carnitine metabolism
-
15591001 10.1196/annals.1320.003 1:CAS:528:DC%2BD2MXjvFOhug%3D%3D
-
Rebouche CJ (2004) Kinetics, pharmacokinetics, and regulation of l-carnitine and acetyl-l-carnitine metabolism. Ann N Y Acad Sci 1033:30-41
-
(2004)
Ann N y Acad Sci
, vol.1033
, pp. 30-41
-
-
Rebouche, C.J.1
-
8
-
-
0012738864
-
Pharmacokinetics of l-carnitine
-
12908852 10.2165/00003088-200342110-00002 1:CAS:528:DC%2BD3sXnslGms74%3D
-
Evans AM, Fornasini G (2003) Pharmacokinetics of l-carnitine. Clin Pharmacokinet 42:941-967
-
(2003)
Clin Pharmacokinet
, vol.42
, pp. 941-967
-
-
Evans, A.M.1
Fornasini, G.2
-
9
-
-
70449707694
-
Effect of l-carnitine on the size of low-density lipoprotein particles in type 2 diabetes mellitus patients treated with simvastatin
-
19604523 10.1016/j.metabol.2009.05.014 1:CAS:528:DC%2BD1MXht1OnsrjO
-
Malaguarnera M, Vacante M, Motta M, Malaguarnera M, Volti GL, Galvano F (2009) Effect of l-carnitine on the size of low-density lipoprotein particles in type 2 diabetes mellitus patients treated with simvastatin. Metabolism 58:1618-1623
-
(2009)
Metabolism
, vol.58
, pp. 1618-1623
-
-
Malaguarnera, M.1
Vacante, M.2
Motta, M.3
Malaguarnera, M.4
Volti, G.L.5
Galvano, F.6
-
10
-
-
58149379405
-
L-Carnitine supplementation reduces oxidized LDL cholesterol in patients with diabetes
-
19056606 10.3945/ajcn.2008.26251 1:CAS:528:DC%2BD1MXnsFKgsw%3D%3D
-
Malaguarnera M, Vacante M, Avitabile T, Malaguarnera M, Cammalleri L, Motta M (2009) l-Carnitine supplementation reduces oxidized LDL cholesterol in patients with diabetes. Am J Clin Nutr 89:71-76
-
(2009)
Am J Clin Nutr
, vol.89
, pp. 71-76
-
-
Malaguarnera, M.1
Vacante, M.2
Avitabile, T.3
Malaguarnera, M.4
Cammalleri, L.5
Motta, M.6
-
11
-
-
68149181537
-
Effects of simvastatin and carnitine versus simvastatin on lipoprotein(a) and apoprotein(a) in type 2 diabetes mellitus
-
10.1517/14656560903081745
-
Galvano F, Volti GL, Malaguarnera M, Avitabile T, Antic T, Vacante M, Malaguarnera M (2006) Effects of simvastatin and carnitine versus simvastatin on lipoprotein(a) and apoprotein(a) in type 2 diabetes mellitus. Expert Opin Pharmacother 10:1875-1882
-
(2006)
Expert Opin Pharmacother
, vol.10
, pp. 1875-1882
-
-
Galvano, F.1
Volti, G.L.2
Malaguarnera, M.3
Avitabile, T.4
Antic, T.5
Vacante, M.6
Malaguarnera, M.7
-
12
-
-
0034769470
-
Carnitine as a free radical scavenger in aging
-
Rani PJA, Panneerselvam C (2001) Carnitine as a free radical scavenger in aging. Exp Gerontol 6:1713-1726
-
(2001)
Exp Gerontol
, vol.6
, pp. 1713-1726
-
-
Rani, P.J.A.1
Panneerselvam, C.2
-
13
-
-
0028608835
-
Protective effect of carnitine on lipoperoxide formation in rat brain
-
7794887
-
Koudelová J, Mourek J, Drahota Z, Rauchová H (1994) Protective effect of carnitine on lipoperoxide formation in rat brain. Physiol Res 43:387-389
-
(1994)
Physiol Res
, vol.43
, pp. 387-389
-
-
Koudelová, J.1
Mourek, J.2
Drahota, Z.3
Rauchová, H.4
-
14
-
-
36849090508
-
L-Carnitine treatment reduces severity of physical and mental fatigue and increases cognitive functions in centenarians: A randomized and controlled clinical trial
-
18065594 1:CAS:528:DC%2BD2sXhsVGhsL%2FI
-
Malaguarnera M, Cammalleri L, Gargante MP, Vacante M, Colonna V, Motta M (2007) l-Carnitine treatment reduces severity of physical and mental fatigue and increases cognitive functions in centenarians: a randomized and controlled clinical trial. Am J Clin Nutr 86:1738-1744
-
(2007)
Am J Clin Nutr
, vol.86
, pp. 1738-1744
-
-
Malaguarnera, M.1
Cammalleri, L.2
Gargante, M.P.3
Vacante, M.4
Colonna, V.5
Motta, M.6
-
15
-
-
83655192001
-
Acetyl-l-carnitine improves cognitive functions in severe hepatic encephalopathy: A randomized and controlled clinical trial
-
21870121 10.1007/s11011-011-9260-z 1:CAS:528:DC%2BC3MXhsVeltb7I
-
Malaguarnera M, Vacante M, Motta M, Giordano M, Malaguarnera G, Bella R, Nunnari G, Rampello L, Pennisi G (2011) Acetyl-l-carnitine improves cognitive functions in severe hepatic encephalopathy: a randomized and controlled clinical trial. Metab Brain Dis 26:281-289
-
(2011)
Metab Brain Dis
, vol.26
, pp. 281-289
-
-
Malaguarnera, M.1
Vacante, M.2
Motta, M.3
Giordano, M.4
Malaguarnera, G.5
Bella, R.6
Nunnari, G.7
Rampello, L.8
Pennisi, G.9
-
16
-
-
79955949749
-
Acetyl-l-carnitine reduces depression and improves quality of life in patients with minimal hepatic encephalopathy
-
21443422 10.3109/00365521.2011.565067 1:CAS:528:DC%2BC3MXmtVWrtbk%3D
-
Malaguarnera M, Bella R, Vacante M, Giordano M, Malaguarnera G, Gargante MP, Motta M, Mistretta A, Rampello L, Pennisi G (2011) Acetyl-l-carnitine reduces depression and improves quality of life in patients with minimal hepatic encephalopathy. Scand J Gastroenterol 46:750-759
-
(2011)
Scand J Gastroenterol
, vol.46
, pp. 750-759
-
-
Malaguarnera, M.1
Bella, R.2
Vacante, M.3
Giordano, M.4
Malaguarnera, G.5
Gargante, M.P.6
Motta, M.7
Mistretta, A.8
Rampello, L.9
Pennisi, G.10
-
17
-
-
33846989018
-
Effects of l-acetylcarnitine on cirrhotic patients with hepatic coma: Randomized double-blind, placebo-controlled trial
-
17080254 10.1007/s10620-006-9187-0 1:CAS:528:DC%2BD2sXktFCksg%3D%3D
-
Malaguarnera M, Pistone G, Astuto M, Vecchio I, Raffaele R, Lo Giudice E, Rampello L (2006) Effects of l-acetylcarnitine on cirrhotic patients with hepatic coma: randomized double-blind, placebo-controlled trial. Dig Dis Sci 51:2242-2247
-
(2006)
Dig Dis Sci
, vol.51
, pp. 2242-2247
-
-
Malaguarnera, M.1
Pistone, G.2
Astuto, M.3
Vecchio, I.4
Raffaele, R.5
Lo Giudice, E.6
Rampello, L.7
-
18
-
-
31544477426
-
Effects of l-carnitine in patients with hepatic encephalopathy
-
16437672 1:CAS:528:DC%2BD28Xhs1Kltrk%3D
-
Malaguarnera M, Pistone G, Elvira R, Leotta C, Scarpello L, Liborio R (2005) Effects of l-carnitine in patients with hepatic encephalopathy. World J Gastroenterol 11:7197-7202
-
(2005)
World J Gastroenterol
, vol.11
, pp. 7197-7202
-
-
Malaguarnera, M.1
Pistone, G.2
Elvira, R.3
Leotta, C.4
Scarpello, L.5
Liborio, R.6
-
19
-
-
84855267416
-
Levocarnitine for valproic-acid-induced hyperammonemic encephalopathy
-
22180549 10.2146/ajhp110049 1:CAS:528:DC%2BC38XotFKht7s%3D
-
Mock CM, Schwetschenau KH (2012) Levocarnitine for valproic-acid-induced hyperammonemic encephalopathy. Am J Health Syst Pharm 69:35-39
-
(2012)
Am J Health Syst Pharm
, vol.69
, pp. 35-39
-
-
Mock, C.M.1
Schwetschenau, K.H.2
-
20
-
-
77952322688
-
Neuroprotective effects of l-carnitine in a transgenic animal model of Huntington's disease
-
19932584 10.1016/j.biopha.2009.06.020 1:CAS:528:DC%2BC3cXltFykurY%3D
-
Vamos E, Voros K, Vecsei L, Klivenyi P (2010) Neuroprotective effects of l-carnitine in a transgenic animal model of Huntington's disease. Biomed Pharmacother 64:282-286
-
(2010)
Biomed Pharmacother
, vol.64
, pp. 282-286
-
-
Vamos, E.1
Voros, K.2
Vecsei, L.3
Klivenyi, P.4
-
21
-
-
0016823810
-
Mini-Mental State" a practical method for grading the cognitive state of patients for the clinician
-
1202204 10.1016/0022-3956(75)90026-6 1:STN:280:DyaE28%2FntFKjtw%3D%3D
-
Folstein M, Folstein SE, McHugh PR (1975) "Mini-Mental State" a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189-198
-
(1975)
J Psychiatr Res
, vol.12
, pp. 189-198
-
-
Folstein, M.1
Folstein, S.E.2
McHugh, P.R.3
-
22
-
-
85009332113
-
Unified Huntington's Disease Rating Scale: Reliability and consistency
-
Huntington Study Group 10.1002/mds.870110204
-
Huntington Study Group (1996) Unified Huntington's Disease Rating Scale: reliability and consistency. Mov Disord 11:136-142
-
(1996)
Mov Disord
, vol.11
, pp. 136-142
-
-
-
23
-
-
0030239661
-
Summary of WIC nutrition risk criteria: A scientific assessment. Committee on Scientific Evaluation of WIC Nutrition Risk Criteria Food and Nutrition Board, Institute of Medicine
-
National Academy of Sciences 10.1016/S0002-8223(96)00257-X
-
National Academy of Sciences (1996) Summary of WIC nutrition risk criteria: a scientific assessment. Committee on Scientific Evaluation of WIC Nutrition Risk Criteria Food and Nutrition Board, Institute of Medicine. J Am Diet Assoc 96:925-930
-
(1996)
J Am Diet Assoc
, vol.96
, pp. 925-930
-
-
-
24
-
-
79551595148
-
Clinical correlates of low serum carnitine levels in hospitalized psychiatric patients
-
20586533 10.3109/15622975.2010.489619
-
Cuturic M, Abramson RK, Moran RR, Hardin JW, Hall AV (2011) Clinical correlates of low serum carnitine levels in hospitalized psychiatric patients. World J Biol Psychiatry 12(1):73-79
-
(2011)
World J Biol Psychiatry
, vol.12
, Issue.1
, pp. 73-79
-
-
Cuturic, M.1
Abramson, R.K.2
Moran, R.R.3
Hardin, J.W.4
Hall, A.V.5
-
25
-
-
76849090445
-
Clinical outcomes and low-dose levocarnitine supplementation in psychiatric inpatients with documented hypocarnitinemia: A retrospective chart review
-
20098226 10.1097/01.pra.0000367773.03636.d1
-
Cuturic M, Abramson RK, Moran RR, Hardin JW (2010) Clinical outcomes and low-dose levocarnitine supplementation in psychiatric inpatients with documented hypocarnitinemia: a retrospective chart review. J Psychiatr Pract 16:5-14
-
(2010)
J Psychiatr Pract
, vol.16
, pp. 5-14
-
-
Cuturic, M.1
Abramson, R.K.2
Moran, R.R.3
Hardin, J.W.4
-
26
-
-
33646518622
-
Disorders of carnitine transport and the carnitine cycle
-
16602102 10.1002/ajmg.c.30087 1:CAS:528:DC%2BD2sXms1WisL4%3D
-
Longo N, di San Amat, Filippo C, Pasquali M (2006) Disorders of carnitine transport and the carnitine cycle. Am J Med Genet C Semin Med Genet 142C:77-85
-
(2006)
Am J Med Genet C Semin Med Genet
, vol.142
, pp. 77-85
-
-
Longo, N.1
Di San, A.2
Filippo, C.3
Pasquali, M.4
-
27
-
-
0030732758
-
Acquired carnitine abnormalities in critically ill children
-
9392402 10.1007/s004310050732 1:CAS:528:DyaK2sXnt1CgtLs%3D
-
Proulx F, Lacroix J, Qureshi IA, Nadeau D, Gauthier M, Lambert M (1997) Acquired carnitine abnormalities in critically ill children. Eur J Pediatr 156:864-869
-
(1997)
Eur J Pediatr
, vol.156
, pp. 864-869
-
-
Proulx, F.1
Lacroix, J.2
Qureshi, I.A.3
Nadeau, D.4
Gauthier, M.5
Lambert, M.6
-
28
-
-
0026513892
-
Prevalence of carnitine depletion in critically ill patients with undernutrition
-
1736038 10.1016/0026-0495(92)90146-2 1:STN:280:DyaK387ktVSlsw%3D%3D
-
Wennberg A, Hyltander A, Sjöberg A, Arfvidsson B, Sandström R, Wickström I, Lundholm K (1992) Prevalence of carnitine depletion in critically ill patients with undernutrition. Metabolism 41:165-171
-
(1992)
Metabolism
, vol.41
, pp. 165-171
-
-
Wennberg, A.1
Hyltander, A.2
Sjöberg, A.3
Arfvidsson, B.4
Sandström, R.5
Wickström, I.6
Lundholm, K.7
-
29
-
-
33646162644
-
Plasma free carnitine in epilepsy children, adolescents and young adults treated with old and new antiepileptic drugs with or without ketogenic diet
-
16376041 10.1016/j.braindev.2005.11.005
-
Coppola G, Epifanio G, Auricchio G, Federico RR, Resicato G, Pascotto A (2006) Plasma free carnitine in epilepsy children, adolescents and young adults treated with old and new antiepileptic drugs with or without ketogenic diet. Brain Dev 28:358-365
-
(2006)
Brain Dev
, vol.28
, pp. 358-365
-
-
Coppola, G.1
Epifanio, G.2
Auricchio, G.3
Federico, R.R.4
Resicato, G.5
Pascotto, A.6
-
30
-
-
0033965329
-
Higher sedentary energy expenditure in patients with Huntington's disease
-
10632102 10.1002/1531-8249(200001)47:1<64: AID-ANA11>3.0.CO;2-S 1:STN:280:DC%2BD3c%2FpsF2lsQ%3D%3D
-
Pratley RE, Salbe AD, Ravussin E, Caviness JN (2000) Higher sedentary energy expenditure in patients with Huntington's disease. Ann Neurol 47:64-70
-
(2000)
Ann Neurol
, vol.47
, pp. 64-70
-
-
Pratley, R.E.1
Salbe, A.D.2
Ravussin, E.3
Caviness, J.N.4
-
31
-
-
0025101871
-
Carnitine deficiency syndromes
-
2187442 10.1016/0887-8994(90)90037-2 1:STN:280:DyaK3c3ltlCrtA%3D%3D
-
Breningstall GN (1990) Carnitine deficiency syndromes. Pediatr Neurol 6:75-81
-
(1990)
Pediatr Neurol
, vol.6
, pp. 75-81
-
-
Breningstall, G.N.1
-
32
-
-
27144539588
-
Science review: Carnitine in the treatment of valproic acid-induced toxicity - What is the evidence?
-
16277730 10.1186/cc3742
-
Lheureux PE, Penaloza A, Zahir S et al (2005) Science review: carnitine in the treatment of valproic acid-induced toxicity - what is the evidence? Crit Care 9:431-440
-
(2005)
Crit Care
, vol.9
, pp. 431-440
-
-
Lheureux, P.E.1
Penaloza, A.2
Zahir, S.3
-
33
-
-
0028850504
-
Primary and secondary carnitine deficiency syndromes
-
Pons R, De Vivo DC (1995) Primary and secondary carnitine deficiency syndromes. J Child Neurol 10(suppl. 2):8-24
-
(1995)
J Child Neurol
, vol.10
, Issue.SUPPL. 2
, pp. 8-24
-
-
Pons, R.1
De Vivo, D.C.2
-
34
-
-
53849128200
-
Acetyl-l-carnitine treatment in minimal hepatic encephalopathy
-
18357530 10.1007/s10620-008-0238-6 1:CAS:528:DC%2BD1cXht1ChsbbO
-
Malaguarnera M, Gargante MP, Cristaldi E, Vacante M, Risino C, Cammalleri L, Pennisi G, Rampello L (2008) Acetyl-l-carnitine treatment in minimal hepatic encephalopathy. Dig Dis Sci 53:3018-3025
-
(2008)
Dig Dis Sci
, vol.53
, pp. 3018-3025
-
-
Malaguarnera, M.1
Gargante, M.P.2
Cristaldi, E.3
Vacante, M.4
Risino, C.5
Cammalleri, L.6
Pennisi, G.7
Rampello, L.8
-
35
-
-
0025050646
-
L-Acetyl-carnitine in Huntington's disease: Double-blind placebo controlled crossover study of drug effects on movement disorder and dementia
-
2143808 10.1002/mds.870050317 1:STN:280:DyaK3czls1SntA%3D%3D
-
Goety CG, Tanner CM, Cohen JA, Thelen JA, Carroll VS, Klawans HL, Fariello RG (1990) l-Acetyl-carnitine in Huntington's disease: double-blind placebo controlled crossover study of drug effects on movement disorder and dementia. Mov Disord 5:263-265
-
(1990)
Mov Disord
, vol.5
, pp. 263-265
-
-
Goety, C.G.1
Tanner, C.M.2
Cohen, J.A.3
Thelen, J.A.4
Carroll, V.S.5
Klawans, H.L.6
Fariello, R.G.7
-
36
-
-
15244352953
-
Free and total carnitine concentrations in pig plasma after oral ingestion of various l-carnitine compounds
-
15830915 10.1024/0300-9831.75.1.3 1:CAS:528:DC%2BD2MXivFCqtrk%3D
-
Eder K, Felgner J, Becker K et al (2005) Free and total carnitine concentrations in pig plasma after oral ingestion of various l-carnitine compounds. Int J Vitam Nutr Res 75:3-9
-
(2005)
Int J Vitam Nutr Res
, vol.75
, pp. 3-9
-
-
Eder, K.1
Felgner, J.2
Becker, K.3
|